METHYLCELLULOSE

METHYLCELLULOSE was reported 2323 times

METHYLCELLULOSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTERTRIGO CANDIDA 2 0.0741
1 SLEEP DISORDER THERAPY 9 0.0455
2 BACTEROIDES INFECTION 11 0.0421
3 APPENDICOLITH 15 0.0388
4 INCISION SITE RASH 2 0.0333
5 ANTACID THERAPY 4 0.0308
6 ANALGESIC THERAPY 9 0.0280
7 DRUG THERAPY 9 0.0265
8 ACTINIC ELASTOSIS 2 0.0263
9 MESENTERIC HAEMATOMA 2 0.0227
10 ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD 2 0.0182
11 DERMATOPHYTOSIS OF NAIL 2 0.0168
12 ADRENOGENITAL SYNDROME 2 0.0148
13 ANTICOAGULANT THERAPY 4 0.0141
14 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 3 0.0120
15 CONGENITAL HIATUS HERNIA 2 0.0088
16 TOTAL LUNG CAPACITY DECREASED 13 0.0081
17 HEPATIC TRAUMA 2 0.0077
18 COLON DYSPLASIA 2 0.0070
19 REFLUX LARYNGITIS 3 0.0068
20 SKIN FIBROSIS 3 0.0062
21 HYPERPHOSPHATAEMIA 12 0.0056
22 DYSPLASTIC NAEVUS 2 0.0055
23 LUNG OPACITY 13 0.0049
24 AORTIC STENOSIS 17 0.0049
25 INTESTINAL FUNCTIONAL DISORDER 3 0.0047
26 ANAL SPHINCTER ATONY 2 0.0047
27 URETHRAL STENOSIS 3 0.0044
28 BLOOD PHOSPHORUS INCREASED 12 0.0044
29 VENOUS INSUFFICIENCY 3 0.0041
30 MYASTHENIC SYNDROME 3 0.0039
31 GENITAL DISCOMFORT 2 0.0036
32 CHOROIDAL DETACHMENT 2 0.0036
33 PULMONARY SARCOIDOSIS 4 0.0036
34 PULMONARY GRANULOMA 4 0.0035
35 ADENOMA BENIGN 3 0.0035
36 HAEMATOMA INFECTION 2 0.0035
37 MUSCLE SWELLING 3 0.0033
38 EXTREMITY CONTRACTURE 2 0.0031
39 IRON DEFICIENCY 13 0.0029
40 ATROPHIC VULVOVAGINITIS 2 0.0027
41 COMPLEX PARTIAL SEIZURES 3 0.0027
42 GINGIVAL ULCERATION 2 0.0027
43 BRONCHITIS BACTERIAL 2 0.0026
44 MONOCLONAL IMMUNOGLOBULIN PRESENT 2 0.0026
45 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13 0.0026
46 EYELID FUNCTION DISORDER 2 0.0025
47 HYPOPHOSPHATAEMIA 18 0.0024
48 INCISION SITE COMPLICATION 2 0.0024
49 ACROCHORDON 3 0.0023
50 BLOOD URIC ACID INCREASED 13 0.0022
51 FOREIGN BODY IN THROAT 7 0.0022
52 BLOOD MAGNESIUM INCREASED 2 0.0022
53 CERUMEN IMPACTION 2 0.0022
54 METASTASES TO ADRENALS 2 0.0022
55 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 2 0.0022
56 MENINGIOMA BENIGN 2 0.0022
57 ARNOLD-CHIARI MALFORMATION 2 0.0021
58 SEBORRHOEIC KERATOSIS 3 0.0021
59 CORRECTIVE LENS USER 2 0.0021
60 BLOOD CALCIUM INCREASED 17 0.0019
61 JOINT CONTRACTURE 2 0.0019
62 MYASTHENIA GRAVIS 15 0.0019
63 INFUSION SITE MASS 2 0.0018
64 SEBORRHOEIC DERMATITIS 3 0.0018
65 FAECES HARD 7 0.0018
66 HYPERLIPIDAEMIA 21 0.0018
67 WOUND INFECTION STAPHYLOCOCCAL 3 0.0017
68 INTERNATIONAL NORMALISED RATIO DECREASED 7 0.0017
69 PAPILLARY THYROID CANCER 3 0.0017
70 DILATATION ATRIAL 2 0.0017
71 APPENDICITIS 16 0.0017
72 TROPONIN INCREASED 13 0.0017
73 MITRAL VALVE DISEASE 3 0.0017
74 INFECTED CYST 2 0.0017
75 INTERVERTEBRAL DISC DISORDER 7 0.0016
76 OESOPHAGEAL SPASM 3 0.0016
77 HAEMATOCRIT ABNORMAL 2 0.0016
78 MALIGNANT MELANOMA IN SITU 2 0.0016
79 HYPERPARATHYROIDISM SECONDARY 4 0.0016
80 BILE DUCT OBSTRUCTION 3 0.0016
81 ACTINIC KERATOSIS 4 0.0015
82 NEPHROGENIC ANAEMIA 7 0.0015
83 MACULAR HOLE 2 0.0015
84 CALCULUS BLADDER 2 0.0015
85 CHANGE OF BOWEL HABIT 3 0.0015
86 INFUSION SITE RASH 2 0.0015
87 VENTRICULAR FIBRILLATION 16 0.0014
88 OESOPHAGEAL STENOSIS 4 0.0014
89 HYPERTONIC BLADDER 4 0.0014
90 MELANOCYTIC NAEVUS 6 0.0014
91 COCCYDYNIA 2 0.0014
92 BLOOD TEST ABNORMAL 19 0.0014
93 CHOLANGIOCARCINOMA 2 0.0013
94 IMPETIGO 2 0.0013
95 ADENOCARCINOMA 3 0.0013
96 CARDIOGENIC SHOCK 19 0.0013
97 ISCHAEMIC CARDIOMYOPATHY 4 0.0013
98 IRON DEFICIENCY ANAEMIA 12 0.0013
99 INGROWING NAIL 3 0.0013
100 COSTOCHONDRITIS 2 0.0012
101 DENTAL IMPLANTATION 2 0.0012
102 COLONIC POLYP 2 0.0012
103 END STAGE RENAL DISEASE 22 0.0012
104 MITRAL VALVE PROLAPSE 2 0.0012
105 VENTRICULAR HYPERTROPHY 3 0.0012
106 VASODILATATION 3 0.0012
107 MALIGNANT PLEURAL EFFUSION 2 0.0012
108 TONGUE ULCERATION 4 0.0012
109 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
110 ACUTE SINUSITIS 2 0.0012
111 LIPOMA 3 0.0012
112 INFUSION SITE DISCHARGE 2 0.0011
113 THROMBOTIC THROMBOCYTOPENIC PURPURA 4 0.0011
114 CARDIAC ABLATION 2 0.0011
115 SKIN WRINKLING 3 0.0011
116 ESSENTIAL HYPERTENSION 2 0.0011
117 GOUT 19 0.0011
118 HYPOREFLEXIA 2 0.0010
119 GINGIVAL RECESSION 2 0.0010
120 ABDOMINAL WALL HAEMATOMA 2 0.0010
121 INCORRECT DOSAGE ADMINISTERED 5 0.0010
122 BACTERIAL INFECTION 19 0.0010
123 REBOUND ACID HYPERSECRETION 3 0.0010
124 NEURALGIA 24 0.0010
125 DIVERTICULUM 7 0.0010
126 EYELID PAIN 2 0.0010
127 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
128 FAECES SOFT 7 0.0010
129 ATRIAL TACHYCARDIA 2 0.0010
130 AORTIC VALVE INCOMPETENCE 4 0.0009
131 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
132 PROCTALGIA 6 0.0009
133 HIATUS HERNIA 12 0.0009
134 INFUSION SITE BRUISING 2 0.0009
135 OCULAR ICTERUS 4 0.0009
136 DIVERTICULUM INTESTINAL 4 0.0009
137 BOWEL MOVEMENT IRREGULARITY 7 0.0009
138 INFUSION SITE HAEMORRHAGE 3 0.0009
139 MIDDLE EAR EFFUSION 2 0.0009
140 SKIN INJURY 3 0.0009
141 ANXIETY DISORDER 3 0.0009
142 PLANTAR FASCIITIS 3 0.0009
143 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
144 ANAL INCONTINENCE 8 0.0009
145 WOUND DEHISCENCE 3 0.0009
146 ULCER 14 0.0009
147 MICTURITION URGENCY 10 0.0009
148 APLASIA PURE RED CELL 3 0.0009
149 CHOKING 17 0.0009
150 FLAT AFFECT 2 0.0009
151 FAECAL INCONTINENCE 4 0.0008
152 BONE LESION 3 0.0008
153 GASTROINTESTINAL OBSTRUCTION 2 0.0008
154 HYPERCHOLESTEROLAEMIA 8 0.0008
155 DERMAL CYST 2 0.0008
156 PRODUCT TASTE ABNORMAL 11 0.0008
157 FREEZING PHENOMENON 3 0.0008
158 INFREQUENT BOWEL MOVEMENTS 2 0.0008
159 CHRONIC SINUSITIS 3 0.0008
160 COMMUNICATION DISORDER 3 0.0008
161 OESOPHAGEAL DISORDER 3 0.0008
162 AORTIC ARTERIOSCLEROSIS 2 0.0008
163 TEMPERATURE INTOLERANCE 8 0.0008
164 PROSTATOMEGALY 3 0.0008
165 SKIN ODOUR ABNORMAL 3 0.0008
166 PHARYNGOLARYNGEAL PAIN 4 0.0008
167 ANORECTAL DISCOMFORT 4 0.0008
168 ATRIAL FLUTTER 6 0.0008
169 FOREIGN BODY 3 0.0007
170 SKIN PAPILLOMA 3 0.0007
171 BODY HEIGHT DECREASED 8 0.0007
172 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
173 CHOLECYSTITIS CHRONIC 5 0.0007
174 ABDOMINAL MASS 2 0.0007
175 BLOOD SODIUM INCREASED 2 0.0007
176 VITAMIN B12 DEFICIENCY 3 0.0007
177 CHONDROPATHY 2 0.0007
178 MIGRAINE WITH AURA 2 0.0007
179 GOITRE 3 0.0007
180 SPINAL STENOSIS 3 0.0007
181 RECTAL HAEMORRHAGE 31 0.0007
182 HAND FRACTURE 5 0.0007
183 BASAL CELL CARCINOMA 11 0.0007
184 PURULENT DISCHARGE 3 0.0007
185 GRANULOCYTOPENIA 4 0.0007
186 ROTATOR CUFF SYNDROME 9 0.0007
187 CHOLECYSTECTOMY 8 0.0007
188 IRRITABLE BOWEL SYNDROME 15 0.0007
189 LUNG CANCER METASTATIC 2 0.0007
190 HEPATIC LESION 3 0.0007
191 HYSTERECTOMY 6 0.0007
192 TONGUE DISCOLOURATION 3 0.0007
193 HYPOVOLAEMIA 4 0.0007
194 SPINAL OSTEOARTHRITIS 6 0.0007
195 ARTHROPOD BITE 5 0.0007
196 RHINITIS ALLERGIC 3 0.0007
197 CONSTIPATION 145 0.0007
198 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
199 EMERGENCY CARE 2 0.0007
200 AORTIC ANEURYSM 5 0.0007
201 CONCUSSION 5 0.0006
202 URINARY INCONTINENCE 19 0.0006
203 BLOOD BLISTER 2 0.0006
204 NASAL DRYNESS 4 0.0006
205 SQUAMOUS CELL CARCINOMA 6 0.0006
206 SPINAL COLUMN STENOSIS 3 0.0006
207 SKIN ABRASION 3 0.0006
208 SPUTUM DISCOLOURED 6 0.0006
209 PRODUCT COMPLAINT 16 0.0006
210 SLEEP APNOEA SYNDROME 12 0.0006
211 APHAGIA 3 0.0006
212 LOOSE TOOTH 2 0.0006
213 VITAMIN D DEFICIENCY 6 0.0006
214 ASCITES 18 0.0006
215 DEAFNESS NEUROSENSORY 2 0.0006
216 BLADDER DISORDER 6 0.0006
217 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
218 HEMIPLEGIA 5 0.0006
219 HYPERAMMONAEMIA 3 0.0006
220 COLITIS ISCHAEMIC 4 0.0006
221 SINUS CONGESTION 8 0.0006
222 ULCER HAEMORRHAGE 4 0.0006
223 OSTEOARTHRITIS 25 0.0006
224 PRODUCT LABEL ISSUE 4 0.0006
225 VITAMIN D DECREASED 5 0.0006
226 PERIPHERAL VASCULAR DISORDER 3 0.0006
227 LEFT VENTRICULAR FAILURE 2 0.0006
228 VENTRICULAR EXTRASYSTOLES 6 0.0006
229 DIVERTICULITIS 16 0.0006
230 NOCTURIA 7 0.0006
231 HYPOPNOEA 2 0.0006
232 PRODUCT ODOUR ABNORMAL 6 0.0006
233 CAROTID ARTERY STENOSIS 2 0.0006
234 EAR PRURITUS 2 0.0006
235 ERYTHEMA NODOSUM 2 0.0006
236 LOGORRHOEA 2 0.0006
237 SEASONAL ALLERGY 8 0.0006
238 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
239 GLOSSITIS 2 0.0006
240 HAEMORRHAGIC DIATHESIS 2 0.0006
241 APPENDICECTOMY 2 0.0006
242 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
243 PRODUCT RESIDUE PRESENT 3 0.0006
244 GINGIVITIS 3 0.0006
245 MUSCLE TIGHTNESS 9 0.0006
246 FACIAL BONES FRACTURE 2 0.0006
247 RESTLESS LEGS SYNDROME 10 0.0005
248 EXOSTOSIS 5 0.0005
249 FAECALOMA 3 0.0005
250 NONSPECIFIC REACTION 3 0.0005
251 GASTROOESOPHAGEAL REFLUX DISEASE 44 0.0005
252 CHOKING SENSATION 3 0.0005
253 HYPOMANIA 2 0.0005
254 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
255 HYPERACUSIS 2 0.0005
256 BLOOD CHOLESTEROL INCREASED 25 0.0005
257 OCULAR DISCOMFORT 6 0.0005
258 DRUG ADMINISTRATION ERROR 16 0.0005
259 PULMONARY FIBROSIS 10 0.0005
260 FREQUENT BOWEL MOVEMENTS 14 0.0005
261 HAEMOLYSIS 4 0.0005
262 SINUS BRADYCARDIA 5 0.0005
263 JOINT INJURY 11 0.0005
264 HYPERTRIGLYCERIDAEMIA 3 0.0005
265 EPIGASTRIC DISCOMFORT 2 0.0005
266 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
267 BODY TEMPERATURE DECREASED 5 0.0005
268 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
269 GINGIVAL PAIN 4 0.0005
270 CYSTITIS 16 0.0005
271 BLEPHARITIS 2 0.0005
272 HIP FRACTURE 16 0.0005
273 RHINITIS 4 0.0005
274 BURSITIS 6 0.0005
275 PLEURAL EFFUSION 30 0.0005
276 CARDIOMEGALY 6 0.0005
277 HICCUPS 4 0.0005
278 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
279 CYST 6 0.0005
280 PRE-EXISTING CONDITION IMPROVED 3 0.0005
281 HYPONATRAEMIA 27 0.0005
282 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
283 ABDOMINAL DISTENSION 50 0.0005
284 INFUSION SITE SWELLING 3 0.0005
285 INFUSION SITE ERYTHEMA 4 0.0005
286 CANDIDA INFECTION 8 0.0005
287 ABSCESS LIMB 2 0.0005
288 ALCOHOLISM 2 0.0005
289 CARDIAC FLUTTER 3 0.0005
290 BLOOD MAGNESIUM DECREASED 4 0.0005
291 MUSCLE STRAIN 4 0.0005
292 HAEMORRHOIDS 9 0.0005
293 BRADYPHRENIA 3 0.0005
294 FLATULENCE 26 0.0005
295 DYSPEPSIA 45 0.0005
296 ASPIRATION 5 0.0005
297 ORAL CANDIDIASIS 6 0.0005
298 DYSGRAPHIA 3 0.0005
299 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
300 ILEUS PARALYTIC 2 0.0004
301 BRONCHIECTASIS 3 0.0004
302 POSTOPERATIVE WOUND INFECTION 3 0.0004
303 AGEUSIA 11 0.0004
304 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
305 ABNORMAL LOSS OF WEIGHT 3 0.0004
306 ABDOMINAL HERNIA 2 0.0004
307 ONYCHOCLASIS 3 0.0004
308 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
309 DROOLING 3 0.0004
310 UROSEPSIS 4 0.0004
311 NERVE COMPRESSION 4 0.0004
312 MENTAL STATUS CHANGES 12 0.0004
313 DRY MOUTH 35 0.0004
314 PERSONALITY CHANGE 4 0.0004
315 DEMENTIA 12 0.0004
316 FLANK PAIN 4 0.0004
317 INCORRECT DRUG ADMINISTRATION DURATION 12 0.0004
318 SLEEP DISORDER 30 0.0004
319 FEELING JITTERY 8 0.0004
320 GESTATIONAL DIABETES 2 0.0004
321 MEDICATION RESIDUE PRESENT 2 0.0004
322 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
323 LIMB OPERATION 2 0.0004
324 PANIC REACTION 3 0.0004
325 GLAUCOMA 8 0.0004
326 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
327 TONGUE DISORDER 3 0.0004
328 ATELECTASIS 4 0.0004
329 DIZZINESS POSTURAL 4 0.0004
330 RASH PUSTULAR 3 0.0004
331 AUTOIMMUNE DISORDER 4 0.0004
332 SINUSITIS 42 0.0004
333 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
334 COELIAC DISEASE 4 0.0004
335 MUSCLE SPASTICITY 5 0.0004
336 DIABETES MELLITUS 31 0.0004
337 PARANOIA 7 0.0004
338 BREATH SOUNDS ABNORMAL 2 0.0004
339 LIGAMENT SPRAIN 4 0.0004
340 BLOOD PRESSURE ABNORMAL 8 0.0004
341 ORTHOSTATIC HYPOTENSION 7 0.0004
342 ANEURYSM 2 0.0004
343 TOOTH EXTRACTION 5 0.0004
344 OVARIAN CYST 4 0.0004
345 SPINAL FRACTURE 8 0.0004
346 BLOOD POTASSIUM DECREASED 12 0.0004
347 BLOOD CREATININE INCREASED 26 0.0004
348 CORONARY ARTERY DISEASE 12 0.0004
349 TENDON PAIN 3 0.0004
350 OSTEOPENIA 6 0.0004
351 VAGINAL DISCHARGE 4 0.0004
352 OEDEMA PERIPHERAL 48 0.0004
353 DYSLIPIDAEMIA 2 0.0004
354 EYELID PTOSIS 4 0.0004
355 AMMONIA INCREASED 2 0.0004
356 VIRAL INFECTION 13 0.0004
357 RENAL FAILURE CHRONIC 3 0.0004
358 INCREASED UPPER AIRWAY SECRETION 2 0.0004
359 GASTROENTERITIS VIRAL 7 0.0004
360 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
361 TOOTHACHE 7 0.0004
362 RESPIRATORY TRACT INFECTION 10 0.0004
363 GASTROINTESTINAL INFLAMMATION 3 0.0004
364 NERVOUSNESS 20 0.0004
365 FOLLICULITIS 4 0.0004
366 PRODUCT USE COMPLAINT 6 0.0004
367 KNEE ARTHROPLASTY 8 0.0004
368 GASTROINTESTINAL DISORDER 34 0.0004
369 RETCHING 8 0.0004
370 ANAL FISTULA 2 0.0004
371 COMPRESSION FRACTURE 2 0.0004
372 ANAL FISSURE 2 0.0004
373 LIVER FUNCTION TEST INCREASED 8 0.0004
374 PHOTOPHOBIA 7 0.0004
375 BLOOD SODIUM DECREASED 7 0.0004
376 RHINORRHOEA 24 0.0004
377 BRUXISM 2 0.0004
378 NEPHROLITHIASIS 17 0.0004
379 BLOOD POTASSIUM INCREASED 6 0.0004
380 HIP SURGERY 2 0.0004
381 CATARACT 22 0.0004
382 DECUBITUS ULCER 3 0.0004
383 PRODUCT PRESCRIBING ISSUE 8 0.0004
384 MUSCULOSKELETAL STIFFNESS 32 0.0004
385 JAW DISORDER 2 0.0004
386 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
387 INTESTINAL ISCHAEMIA 2 0.0004
388 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
389 DENTAL CARIES 4 0.0004
390 EAR PAIN 7 0.0004
391 MALNUTRITION 4 0.0004
392 ABDOMINAL PAIN 83 0.0004
393 SNEEZING 8 0.0004
394 ACUTE PULMONARY OEDEMA 2 0.0004
395 ARTHRITIS 28 0.0004
396 BLOOD CALCIUM DECREASED 4 0.0004
397 EYE INFECTION 4 0.0004
398 MITRAL VALVE INCOMPETENCE 4 0.0004
399 INADEQUATE ANALGESIA 3 0.0004
400 HAEMATOCRIT DECREASED 7 0.0004
401 URINARY TRACT INFECTION 60 0.0004
402 UPPER LIMB FRACTURE 7 0.0004
403 HYPERTONIA 2 0.0003
404 FULL BLOOD COUNT DECREASED 7 0.0003
405 CARDIAC MURMUR 3 0.0003
406 PARAESTHESIA ORAL 5 0.0003
407 DIPLOPIA 9 0.0003
408 HYPERVENTILATION 2 0.0003
409 INTENTIONAL PRODUCT MISUSE 30 0.0003
410 OSTEOPOROSIS 14 0.0003
411 PRODUCT COMMUNICATION ISSUE 3 0.0003
412 HYPERCHLORHYDRIA 2 0.0003
413 LUNG INFILTRATION 3 0.0003
414 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
415 HEAD DISCOMFORT 6 0.0003
416 EAR INFECTION 9 0.0003
417 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
418 DYSPHAGIA 32 0.0003
419 PULMONARY HYPERTENSION 7 0.0003
420 THIRST 6 0.0003
421 CHOLECYSTITIS 4 0.0003
422 CARDIAC PACEMAKER INSERTION 2 0.0003
423 BALANCE DISORDER 29 0.0003
424 CHOLELITHIASIS 11 0.0003
425 MACULAR DEGENERATION 4 0.0003
426 MOUTH ULCERATION 7 0.0003
427 HOT FLUSH 25 0.0003
428 HYPOAESTHESIA ORAL 5 0.0003
429 SWELLING 31 0.0003
430 DEVICE FAILURE 5 0.0003
431 INCREASED TENDENCY TO BRUISE 3 0.0003
432 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
433 PRODUCT USE ISSUE 61 0.0003
434 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
435 MUSCULOSKELETAL CHEST PAIN 5 0.0003
436 DYSGEUSIA 24 0.0003
437 FAECES DISCOLOURED 7 0.0003
438 PHARYNGITIS 4 0.0003
439 HEPATIC STEATOSIS 6 0.0003
440 INFUSION SITE EXTRAVASATION 2 0.0003
441 HAEMATURIA 11 0.0003
442 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
443 SWOLLEN TONGUE 10 0.0003
444 DYSKINESIA 13 0.0003
445 DYSPNOEA EXERTIONAL 12 0.0003
446 INTESTINAL OBSTRUCTION 12 0.0003
447 ATRIAL FIBRILLATION 31 0.0003
448 SPINAL DISORDER 3 0.0003
449 CHRONIC KIDNEY DISEASE 24 0.0003
450 MUSCLE ATROPHY 4 0.0003
451 ABDOMINAL PAIN UPPER 65 0.0003
452 FALL 105 0.0003
453 RED BLOOD CELL COUNT DECREASED 9 0.0003
454 PRODUCTIVE COUGH 15 0.0003
455 HYPERSOMNIA 9 0.0003
456 HAEMOGLOBIN ABNORMAL 2 0.0003
457 THROMBOSIS 25 0.0003
458 BRONCHITIS 23 0.0003
459 ERUCTATION 6 0.0003
460 CHROMATURIA 7 0.0003
461 DYSSTASIA 9 0.0003
462 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
463 BACK DISORDER 5 0.0003
464 DEHYDRATION 41 0.0003
465 VITREOUS FLOATERS 3 0.0003
466 PULMONARY EMBOLISM 29 0.0003
467 HYPOGAMMAGLOBULINAEMIA 2 0.0003
468 NECK PAIN 17 0.0003
469 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
470 RENAL INJURY 9 0.0003
471 APPETITE DISORDER 2 0.0003
472 PRESCRIBED UNDERDOSE 6 0.0003
473 PRODUCT PHYSICAL ISSUE 6 0.0003
474 SEPSIS 33 0.0003
475 LIMB INJURY 8 0.0003
476 GAIT DISTURBANCE 56 0.0003
477 EAR DISCOMFORT 3 0.0003
478 DYSARTHRIA 11 0.0003
479 DIARRHOEA 188 0.0003
480 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
481 LYMPHOEDEMA 2 0.0003
482 MENTAL IMPAIRMENT 7 0.0003
483 MYALGIA 49 0.0003
484 PETECHIAE 3 0.0003
485 WEIGHT FLUCTUATION 3 0.0003
486 EXTRASYSTOLES 2 0.0003
487 MUSCULOSKELETAL PAIN 15 0.0003
488 DEFAECATION URGENCY 2 0.0003
489 HEAD INJURY 9 0.0003
490 SOMNOLENCE 57 0.0003
491 LYMPHOCYTE COUNT DECREASED 5 0.0003
492 PAIN IN JAW 8 0.0003
493 HYPOTHYROIDISM 9 0.0003
494 SINUS TACHYCARDIA 4 0.0003
495 FEAR OF INJECTION 2 0.0003
496 BACK PAIN 65 0.0003
497 SUBDURAL HAEMATOMA 4 0.0003
498 ANOSMIA 4 0.0003
499 INJECTION SITE HAEMATOMA 4 0.0003
500 LIVER FUNCTION TEST ABNORMAL 8 0.0003
501 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
502 ASTHENIA 103 0.0003
503 HYPOPHAGIA 7 0.0003
504 NEUROPATHY PERIPHERAL 26 0.0003
505 DISEASE RECURRENCE 13 0.0003
506 NASAL CONGESTION 16 0.0003
507 HYPERHIDROSIS 35 0.0003
508 DYSURIA 10 0.0003
509 FOOT DEFORMITY 3 0.0003
510 CONTUSION 26 0.0003
511 TOOTH DISORDER 6 0.0003
512 NERVE INJURY 3 0.0003
513 FEELING DRUNK 2 0.0003
514 PULMONARY MASS 4 0.0003
515 ORAL PAIN 6 0.0003
516 SKIN INFECTION 3 0.0003
517 INTESTINAL PERFORATION 3 0.0003
518 HYDRONEPHROSIS 2 0.0003
519 OXYGEN SATURATION DECREASED 15 0.0003
520 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
521 GASTRITIS 7 0.0003
522 STATUS EPILEPTICUS 3 0.0003
523 POLLAKIURIA 11 0.0003
524 SCAB 3 0.0003
525 MIGRAINE 25 0.0003
526 HERPES ZOSTER 15 0.0003
527 PRODUCT SUBSTITUTION ISSUE 15 0.0003
528 PHARYNGEAL OEDEMA 4 0.0003
529 ACUTE RESPIRATORY FAILURE 5 0.0003
530 SYNCOPE 26 0.0003
531 PERICARDIAL EFFUSION 6 0.0003
532 TREMOR 43 0.0003
533 OEDEMA 14 0.0003
534 CELLULITIS 13 0.0003
535 PAIN IN EXTREMITY 76 0.0003
536 WEIGHT DECREASED 72 0.0003
537 COUGH 72 0.0003
538 ABDOMINAL DISCOMFORT 43 0.0003
539 HEART RATE DECREASED 9 0.0003
540 HYPOXIA 9 0.0003
541 HYPOACUSIS 11 0.0003
542 AFFECTIVE DISORDER 2 0.0003
543 NAUSEA 201 0.0003
544 BLOOD IRON DECREASED 3 0.0003
545 HEART RATE INCREASED 25 0.0003
546 BLOOD ALBUMIN DECREASED 2 0.0003
547 MYOCLONUS 3 0.0003
548 ABSCESS 4 0.0003
549 MUSCLE SPASMS 46 0.0003
550 HYPERTENSION 53 0.0002
551 BLOOD DISORDER 2 0.0002
552 MIOSIS 2 0.0002
553 DRUG INTOLERANCE 24 0.0002
554 LOCALISED INFECTION 6 0.0002
555 ANAEMIA 47 0.0002
556 IMPAIRED HEALING 8 0.0002
557 HAEMOGLOBIN DECREASED 25 0.0002
558 HYPERAESTHESIA 2 0.0002
559 ESCHERICHIA INFECTION 2 0.0002
560 INFLUENZA 27 0.0002
561 BLOOD PRESSURE INCREASED 37 0.0002
562 HAIR COLOUR CHANGES 3 0.0002
563 VISUAL ACUITY REDUCED 8 0.0002
564 EMBOLISM 2 0.0002
565 BLOOD PRESSURE DECREASED 16 0.0002
566 EXPIRED PRODUCT ADMINISTERED 8 0.0002
567 DYSPNOEA 136 0.0002
568 MEMORY IMPAIRMENT 33 0.0002
569 PNEUMONIA ASPIRATION 6 0.0002
570 COAGULOPATHY 4 0.0002
571 TINNITUS 11 0.0002
572 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
573 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
574 BLOOD UREA INCREASED 4 0.0002
575 HALLUCINATION 18 0.0002
576 FEELING ABNORMAL 57 0.0002
577 MUSCULAR WEAKNESS 27 0.0002
578 CHEST PAIN 44 0.0002
579 ACUTE MYOCARDIAL INFARCTION 7 0.0002
580 LABORATORY TEST ABNORMAL 7 0.0002
581 HALLUCINATION, VISUAL 5 0.0002
582 DIZZINESS 117 0.0002
583 PLATELET COUNT DECREASED 25 0.0002
584 RESPIRATORY DISORDER 7 0.0002
585 FATIGUE 182 0.0002
586 ANOREXIA 3 0.0002
587 CARDIAC OPERATION 2 0.0002
588 MUSCULOSKELETAL DISCOMFORT 4 0.0002
589 ANURIA 2 0.0002
590 MULTI-ORGAN FAILURE 4 0.0002
591 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
592 EYE PAIN 13 0.0002
593 MULTIPLE SCLEROSIS 11 0.0002
594 JOINT STIFFNESS 6 0.0002
595 BEDRIDDEN 3 0.0002
596 WEIGHT INCREASED 51 0.0002
597 GROIN PAIN 2 0.0002
598 DISORIENTATION 9 0.0002
599 EMOTIONAL DISORDER 7 0.0002
600 OROPHARYNGEAL PAIN 21 0.0002
601 LIMB DISCOMFORT 7 0.0002
602 LETHARGY 13 0.0002
603 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
604 LIVER DISORDER 10 0.0002
605 EYE HAEMORRHAGE 3 0.0002
606 FACIAL PAIN 2 0.0002
607 MALIGNANT MELANOMA 3 0.0002
608 JOINT RANGE OF MOTION DECREASED 3 0.0002
609 ARTHRALGIA 93 0.0002
610 CONDITION AGGRAVATED 68 0.0002
611 PULMONARY OEDEMA 10 0.0002
612 DYSPHONIA 13 0.0002
613 SURGERY 13 0.0002
614 DEVELOPMENTAL DELAY 2 0.0002
615 RASH PRURITIC 12 0.0002
616 HEART RATE IRREGULAR 5 0.0002
617 ASTHMA 25 0.0002
618 HYPOAESTHESIA 33 0.0002
619 IMPAIRED GASTRIC EMPTYING 3 0.0002
620 BONE DISORDER 4 0.0002
621 PERIPHERAL COLDNESS 3 0.0002
622 MOVEMENT DISORDER 7 0.0002
623 ABNORMAL DREAMS 6 0.0002
624 GRAND MAL CONVULSION 2 0.0002
625 FLUID RETENTION 11 0.0002
626 PARAESTHESIA 34 0.0002
627 ARTHROPATHY 12 0.0002
628 ORAL DISCOMFORT 3 0.0002
629 DECREASED APPETITE 50 0.0002
630 AMNESIA 14 0.0002
631 HAEMOPTYSIS 6 0.0002
632 EYE SWELLING 8 0.0002
633 CHEST DISCOMFORT 22 0.0002
634 THINKING ABNORMAL 4 0.0002
635 MASS 3 0.0002
636 HEPATIC ENCEPHALOPATHY 2 0.0002
637 CARPAL TUNNEL SYNDROME 3 0.0002
638 PERIPHERAL SWELLING 33 0.0002
639 DIARRHOEA HAEMORRHAGIC 2 0.0002
640 EPISTAXIS 16 0.0002
641 DEVICE OCCLUSION 3 0.0002
642 HEPATIC CIRRHOSIS 4 0.0002
643 BLINDNESS UNILATERAL 3 0.0002
644 ARTERIOSCLEROSIS 2 0.0002
645 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
646 RENAL FAILURE ACUTE 9 0.0002
647 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
648 CARDIAC FAILURE CONGESTIVE 17 0.0002
649 VISION BLURRED 29 0.0002
650 FOOT FRACTURE 4 0.0002
651 COVID-19 37 0.0002
652 GASTRIC ULCER 4 0.0002
653 BRONCHOSPASM 3 0.0002
654 PNEUMONIA 68 0.0002
655 EYE INFLAMMATION 2 0.0002
656 IMPAIRED QUALITY OF LIFE 3 0.0002
657 ANXIETY 59 0.0002
658 PRESCRIBED OVERDOSE 4 0.0002
659 HYPOKINESIA 3 0.0002
660 INSOMNIA 55 0.0002
661 FLUID OVERLOAD 3 0.0002
662 FIBROMYALGIA 5 0.0002
663 APATHY 3 0.0002
664 GASTROENTERITIS 3 0.0002
665 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 37 0.0002
666 PALPITATIONS 24 0.0002
667 ORAL HERPES 4 0.0002
668 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
669 GASTRIC DISORDER 7 0.0002
670 KIDNEY INFECTION 4 0.0002
671 RENAL FAILURE 27 0.0002
672 KNEE OPERATION 2 0.0002
673 HOSPICE CARE 2 0.0002
674 RENAL IMPAIRMENT 17 0.0002
675 VOMITING 95 0.0002
676 SINUS DISORDER 4 0.0002
677 ABNORMAL BEHAVIOUR 8 0.0002
678 DELIRIUM 7 0.0002
679 IMMUNODEFICIENCY 3 0.0002
680 HAEMORRHAGE 21 0.0002
681 HAEMORRHAGE INTRACRANIAL 3 0.0002
682 RASH MACULAR 7 0.0002
683 HAEMATOCHEZIA 11 0.0002
684 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
685 APHASIA 6 0.0002
686 LACRIMATION INCREASED 6 0.0002
687 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
688 CONFUSIONAL STATE 32 0.0002
689 BLOOD COUNT ABNORMAL 3 0.0002
690 ABDOMINAL PAIN LOWER 5 0.0002
691 HAEMATEMESIS 5 0.0002
692 DRUG LEVEL DECREASED 2 0.0002
693 MALAISE 86 0.0002
694 HIP ARTHROPLASTY 3 0.0002
695 FEELING HOT 12 0.0002
696 EUPHORIC MOOD 2 0.0002
697 HYPOKALAEMIA 9 0.0002
698 THYROID DISORDER 3 0.0002
699 LYMPHOMA 3 0.0002
700 ANKLE FRACTURE 3 0.0002
701 UNRESPONSIVE TO STIMULI 5 0.0002
702 DELUSION 3 0.0002
703 EYE DISCHARGE 2 0.0002
704 CARDIAC DISORDER 18 0.0002
705 HYPERGLYCAEMIA 7 0.0002
706 PANIC ATTACK 7 0.0002
707 UNDERDOSE 14 0.0002
708 RESTLESSNESS 7 0.0002
709 DEAFNESS 5 0.0002
710 EYE IRRITATION 11 0.0002
711 HEADACHE 119 0.0002
712 JOINT DISLOCATION 2 0.0002
713 RESPIRATORY TRACT CONGESTION 3 0.0002
714 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
715 OBESITY 3 0.0002
716 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
717 SCIATICA 3 0.0002
718 EATING DISORDER 4 0.0002
719 BREAST PAIN 2 0.0002
720 FLUSHING 19 0.0002
721 HEREDITARY ANGIOEDEMA 2 0.0002
722 NIGHT SWEATS 6 0.0002
723 PRURITUS GENERALISED 4 0.0002
724 DEEP VEIN THROMBOSIS 12 0.0002
725 BIPOLAR DISORDER 2 0.0002
726 PAIN 113 0.0002
727 BACK INJURY 2 0.0002
728 PNEUMONITIS 5 0.0002
729 MOOD ALTERED 5 0.0002
730 METASTASES TO BONE 3 0.0002
731 MULTIPLE FRACTURES 3 0.0002
732 JOINT SWELLING 22 0.0002
733 MELAENA 4 0.0002
734 APPLICATION SITE PAIN 4 0.0002
735 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
736 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
737 FUNGAL INFECTION 6 0.0002
738 URINARY RETENTION 6 0.0002
739 PLASMA CELL MYELOMA 7 0.0002
740 CHILLS 21 0.0002
741 GLOSSODYNIA 4 0.0002
742 DEPRESSION 40 0.0002
743 INTENTIONAL DOSE OMISSION 5 0.0002
744 DERMATITIS CONTACT 2 0.0002
745 PRURITUS 67 0.0002
746 SKIN DISCOLOURATION 8 0.0002
747 NASOPHARYNGITIS 32 0.0002
748 EYELID OEDEMA 2 0.0002
749 LOCAL SWELLING 3 0.0002
750 UNEVALUABLE EVENT 13 0.0002
751 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
752 LUNG NEOPLASM MALIGNANT 7 0.0002
753 LYMPHADENOPATHY 6 0.0002
754 HYPOTENSION 34 0.0002
755 PSYCHOTIC DISORDER 5 0.0002
756 SWELLING FACE 11 0.0002
757 BACTERAEMIA 2 0.0002
758 ATAXIA 2 0.0002
759 PYREXIA 58 0.0002
760 DRUG EFFECT DECREASED 9 0.0002
761 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
762 IRRITABILITY 10 0.0002
763 LEUKOCYTOSIS 3 0.0002
764 HEPATITIS C 2 0.0002
765 DRUG EFFECT INCOMPLETE 6 0.0002
766 STOMATITIS 10 0.0002
767 ADRENAL INSUFFICIENCY 2 0.0002
768 AGITATION 12 0.0002
769 INJECTION SITE URTICARIA 4 0.0002
770 INJECTION SITE MASS 6 0.0002
771 HYPERCALCAEMIA 2 0.0002
772 CONJUNCTIVITIS 3 0.0002
773 OSTEONECROSIS OF JAW 4 0.0002
774 GENERALISED OEDEMA 2 0.0002
775 FEMUR FRACTURE 5 0.0002
776 PANCYTOPENIA 9 0.0002
777 MIDDLE INSOMNIA 3 0.0002
778 DRY EYE 8 0.0002
779 COLITIS 6 0.0002
780 CARDIOVASCULAR DISORDER 4 0.0002
781 CONVULSION 9 0.0002
782 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
783 INJECTION SITE SWELLING 12 0.0002
784 COLITIS ULCERATIVE 7 0.0002
785 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
786 LOWER LIMB FRACTURE 3 0.0002
787 DRUG PRESCRIBING ERROR 3 0.0002
788 ERECTILE DYSFUNCTION 4 0.0002
789 THERAPY NON-RESPONDER 7 0.0002
790 ILLNESS 16 0.0002
791 HERNIA 3 0.0002
792 ANAPHYLACTIC SHOCK 4 0.0002
793 HAEMATOMA 4 0.0002
794 SPEECH DISORDER 8 0.0002
795 WHEEZING 9 0.0002
796 IMMUNE SYSTEM DISORDER 2 0.0002
797 DEPRESSED MOOD 8 0.0002
798 DRUG DOSE OMISSION 25 0.0002
799 BRADYCARDIA 8 0.0002
800 ADVERSE REACTION 2 0.0002
801 LIP SWELLING 5 0.0001
802 INCORRECT DOSE ADMINISTERED 34 0.0001
803 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
804 FEEDING DISORDER 3 0.0001
805 THROAT TIGHTNESS 4 0.0001
806 ANGER 5 0.0001
807 DISCOMFORT 9 0.0001
808 OCULAR HYPERAEMIA 7 0.0001
809 GINGIVAL BLEEDING 2 0.0001
810 RASH ERYTHEMATOUS 7 0.0001
811 CORONARY ARTERY OCCLUSION 2 0.0001
812 SKIN LESION 4 0.0001
813 RESPIRATORY DISTRESS 4 0.0001
814 NIGHTMARE 5 0.0001
815 FEELING COLD 4 0.0001
816 HUNGER 2 0.0001
817 INTENTIONAL DRUG MISUSE 3 0.0001
818 BLOOD GLUCOSE INCREASED 27 0.0001
819 APHONIA 2 0.0001
820 DERMATITIS 3 0.0001
821 BURNING SENSATION 10 0.0001
822 INJURY 10 0.0001
823 RASH 62 0.0001
824 TARDIVE DYSKINESIA 4 0.0001
825 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
826 HYPERSENSITIVITY 26 0.0001
827 AGGRESSION 7 0.0001
828 CEREBRAL HAEMORRHAGE 5 0.0001
829 OFF LABEL USE 122 0.0001
830 INJECTION SITE BRUISING 11 0.0001
831 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
832 CRYING 5 0.0001
833 ALOPECIA 27 0.0001
834 THERAPY CESSATION 7 0.0001
835 INFUSION RELATED REACTION 9 0.0001
836 RASH MACULO-PAPULAR 3 0.0001
837 INJECTION SITE PRURITUS 9 0.0001
838 COLON CANCER 2 0.0001
839 THROAT IRRITATION 6 0.0001
840 INFLUENZA LIKE ILLNESS 11 0.0001
841 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 27 0.0001
842 LOSS OF CONSCIOUSNESS 17 0.0001
843 APPLICATION SITE PRURITUS 3 0.0001
844 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
845 HEPATIC ENZYME INCREASED 9 0.0001
846 ECONOMIC PROBLEM 2 0.0001
847 PRODUCT AVAILABILITY ISSUE 3 0.0001
848 ILL-DEFINED DISORDER 8 0.0001
849 EPILEPSY 4 0.0001
850 ACUTE KIDNEY INJURY 20 0.0001
851 SKIN EXFOLIATION 11 0.0001
852 INJECTION SITE RASH 4 0.0001
853 ADVERSE EVENT 12 0.0001
854 MUSCLE TWITCHING 3 0.0001
855 RENAL DISORDER 6 0.0001
856 EJECTION FRACTION DECREASED 2 0.0001
857 ACUTE MYELOID LEUKAEMIA 2 0.0001
858 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
859 URTICARIA 21 0.0001
860 THROMBOCYTOPENIA 14 0.0001
861 PRODUCT QUALITY ISSUE 17 0.0001
862 BLOOD PRESSURE FLUCTUATION 3 0.0001
863 BLISTER 7 0.0001
864 INTERSTITIAL LUNG DISEASE 6 0.0001
865 EXTRA DOSE ADMINISTERED 5 0.0001
866 PRESYNCOPE 3 0.0001
867 CEREBRAL INFARCTION 3 0.0001
868 NEUTROPHIL COUNT DECREASED 5 0.0001
869 PRODUCT DOSE OMISSION 8 0.0001
870 ADVERSE DRUG REACTION 11 0.0001
871 DRUG INEFFECTIVE 161 0.0001
872 STAPHYLOCOCCAL INFECTION 4 0.0001
873 SEIZURE 14 0.0001
874 DRUG LEVEL INCREASED 2 0.0001
875 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
876 DRY SKIN 16 0.0001
877 CEREBROVASCULAR ACCIDENT 20 0.0001
878 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
879 INFECTION 17 0.0001
880 ERYTHEMA 24 0.0001
881 RASH GENERALISED 3 0.0001
882 NEOPLASM PROGRESSION 4 0.0001
883 VERTIGO 7 0.0001
884 HYPERKALAEMIA 4 0.0001
885 COLD SWEAT 2 0.0001
886 VISUAL IMPAIRMENT 14 0.0001
887 INJECTION SITE HAEMORRHAGE 9 0.0001
888 THERAPY INTERRUPTED 8 0.0001
889 FEAR 3 0.0001
890 JAUNDICE 3 0.0001
891 DISTURBANCE IN ATTENTION 6 0.0001
892 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
893 ACCIDENTAL OVERDOSE 4 0.0001
894 SKIN IRRITATION 5 0.0001
895 PROCEDURAL PAIN 3 0.0001
896 COGNITIVE DISORDER 5 0.0001
897 HYPOCALCAEMIA 2 0.0001
898 BLOOD URINE PRESENT 2 0.0001
899 INJECTION SITE ERYTHEMA 13 0.0001
900 ANGINA PECTORIS 3 0.0001
901 INCREASED APPETITE 2 0.0001
902 BLOOD GLUCOSE DECREASED 5 0.0001
903 HYPOGLYCAEMIA 5 0.0001
904 DRUG WITHDRAWAL SYNDROME 9 0.0001
905 TACHYCARDIA 9 0.0001
906 INJECTION SITE PAIN 31 0.0001
907 PREMATURE BABY 3 0.0001
908 CARDIAC FAILURE 8 0.0001
909 PRODUCT DOSE OMISSION ISSUE 29 0.0001
910 HOSPITALISATION 15 0.0001
911 MOBILITY DECREASED 7 0.0001
912 INJECTION SITE WARMTH 2 0.0001
913 TREATMENT FAILURE 8 0.0001
914 NERVOUS SYSTEM DISORDER 3 0.0001
915 ROAD TRAFFIC ACCIDENT 4 0.0001
916 SEPTIC SHOCK 4 0.0001
917 PSORIASIS 12 0.0001
918 TREATMENT NONCOMPLIANCE 5 0.0001
919 EYE DISORDER 3 0.0001
920 SKIN DISORDER 3 0.0001
921 HEPATOTOXICITY 2 0.0001
922 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
923 EYE PRURITUS 3 0.0001
924 DEVICE ISSUE 8 0.0001
925 TYPE 2 DIABETES MELLITUS 3 0.0001
926 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
927 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
928 SUICIDAL IDEATION 8 0.0001
929 MYOCARDIAL INFARCTION 15 0.0001
930 BONE PAIN 5 0.0001
931 DISEASE PROGRESSION 10 0.0001
932 ARRHYTHMIA 4 0.0001
933 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
934 PRODUCT ADHESION ISSUE 3 0.0001
935 OVERDOSE 18 0.0001
936 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
937 DRUG INTERACTION 13 0.0001
938 ABASIA 2 0.0001
939 RHEUMATOID ARTHRITIS 9 0.0001
940 INFLAMMATION 4 0.0001
941 EXPOSURE VIA SKIN CONTACT 2 0.0001
942 APPLICATION SITE ERYTHEMA 2 0.0001
943 ANHEDONIA 2 0.0001
944 DERMATITIS ATOPIC 4 0.0001
945 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
946 PANCREATITIS 4 0.0001
947 NEOPLASM MALIGNANT 5 0.0001
948 BREAST CANCER FEMALE 2 0.0001
949 PROSTATE CANCER 6 0.0001
950 BLOOD BILIRUBIN INCREASED 2 0.0001
951 PSORIATIC ARTHROPATHY 3 0.0001
952 INJECTION SITE REACTION 5 0.0001
953 ANAPHYLACTIC REACTION 4 0.0001
954 MEDICATION ERROR 4 0.0001
955 VAGINAL HAEMORRHAGE 3 0.0001
956 MENTAL DISORDER 3 0.0001
957 RESPIRATORY FAILURE 5 0.0001
958 DRUG DEPENDENCE 11 0.0001
959 ANGIOEDEMA 3 0.0001
960 HEPATIC FAILURE 2 0.0001
961 NEUTROPENIA 9 0.0001
962 ACNE 5 0.0001
963 GYNAECOMASTIA 2 0.0001
964 DRUG-INDUCED LIVER INJURY 2 0.0001
965 MOOD SWINGS 2 0.0001
966 DEATH 54 0.0001
967 METABOLIC ACIDOSIS 2 0.0001
968 LACTIC ACIDOSIS 2 0.0001
969 LUNG DISORDER 3 0.0001
970 GAIT INABILITY 2 0.0001
971 DEVICE USE ERROR 2 0.0001
972 ECZEMA 3 0.0001
973 DEVICE MALFUNCTION 4 0.0001
974 EMOTIONAL DISTRESS 6 0.0000
975 BLINDNESS 2 0.0000
976 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
977 CARDIAC ARREST 4 0.0000
978 CARDIO-RESPIRATORY ARREST 2 0.0000
979 PRODUCT STORAGE ERROR 4 0.0000
980 COMA 2 0.0000
981 SKIN BURNING SENSATION 3 0.0000
982 LEUKOPENIA 2 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
984 NO ADVERSE EVENT 7 0.0000
985 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
986 BLADDER CANCER 2 0.0000
987 DEVICE DIFFICULT TO USE 2 0.0000
988 FEBRILE NEUTROPENIA 2 0.0000
989 DRUG DOSE OMISSION BY DEVICE 2 0.0000
990 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000